Over the past 20 weeks, the data indicates a substantial decline in the proportion of respiratory specimens testing positive for influenza, with a peak ratio of positive specimens at 26.13% in week 1, which gradually decreased to 2.38% by week 20. This trend is consistent across both Influenza A and B, with Influenza A showing a more pronounced drop from 25.07% to 1.31%, while Influenza B decreased less significantly from 1.28% to 1.07% in the same period. The highest number of specimens tested was at the beginning of the period (53,364), which then decreased week by week to the lowest number of 7,951 in week 20, potentially reflecting a seasonal decline in influenza activity or a reduction in testing. The observed decrease in the ratio of positive specimens indicates a diminishing prevalence of influenza, which could result in reduced strain on healthcare resources; however, consistent testing remains important to monitor for potential surges or new strains. Moreover, the sustained presence of both Influenza A and B underscores the need for ongoing public health measures, including vaccination and surveillance, to manage influenza-related health risks.